Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.
Corporate Presentation
Stock Information
Change
High
Data Provided by Refinitiv. Minimum 15 minutes delayed.